Stock PMC PHARMEDIC PHARMACEUTICAL MEDICINAL
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pharmedic Pharmaceutical Medicinal

Equities

PMC

VN000000PMC3

Pharmaceuticals

End-of-day quote HANOI S.E.
Other stock markets
 03:30:00 23/05/2024 am IST 		5-day change 1st Jan Change
86,800 VND -0.69% Intraday chart for Pharmedic Pharmaceutical Medicinal +8.50% +0.81%
22/04 Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
17/01 Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 5,29,157 4,92,760 5,36,623 6,11,284 7,93,269 8,03,535
Enterprise Value (EV) 1 3,59,217 3,23,035 3,10,097 3,39,723 4,99,715 5,41,282
P/E ratio 9.84 x 9.07 x 9.85 x 12.9 x 13 x 13.2 x
Yield - - - 3.66% 3.53% 17.4%
Capitalization / Revenue 1.16 x 1.06 x 1.16 x 1.48 x 1.68 x 1.66 x
EV / Revenue 0.79 x 0.7 x 0.67 x 0.82 x 1.06 x 1.12 x
EV / EBITDA 3.74 x 3.34 x 3.11 x 3.94 x 4.85 x 5.63 x
EV / FCF 7.49 x 11.9 x 3.09 x 5.22 x 13.3 x 5.19 x
FCF Yield 13.3% 8.41% 32.3% 19.1% 7.52% 19.3%
Price to Book 2.18 x 1.48 x 1.47 x 1.57 x 1.85 x 2.34 x
Nbr of stocks (in thousands) 9,333 9,333 9,333 9,333 9,333 9,333
Reference price 2 56,700 52,800 57,500 65,500 85,000 86,100
Announcement Date 28/03/19 27/03/20 23/03/21 31/03/22 29/03/23 28/03/24
1VND in Million2VND
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 4,54,572 4,64,772 4,60,764 4,14,232 4,72,274 4,85,186
EBITDA 1 96,052 96,780 99,772 86,313 1,03,081 96,124
EBIT 1 84,986 85,823 85,687 72,580 90,768 84,408
Operating Margin 18.7% 18.47% 18.6% 17.52% 19.22% 17.4%
Earnings before Tax (EBT) 1 92,560 93,457 93,700 81,284 1,04,480 1,04,602
Net income 1 73,649 74,420 74,618 64,760 83,416 83,564
Net margin 16.2% 16.01% 16.19% 15.63% 17.66% 17.22%
EPS 2 5,761 5,821 5,837 5,066 6,525 6,536
Free Cash Flow 1 47,943 27,156 1,00,238 65,033 37,573 1,04,285
FCF margin 10.55% 5.84% 21.75% 15.7% 7.96% 21.49%
FCF Conversion (EBITDA) 49.91% 28.06% 100.47% 75.35% 36.45% 108.49%
FCF Conversion (Net income) 65.1% 36.49% 134.33% 100.42% 45.04% 124.8%
Dividend per Share - - - 2,400 3,000 15,000
Announcement Date 28/03/19 27/03/20 23/03/21 31/03/22 29/03/23 28/03/24
1VND in Million2VND
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 1,69,940 1,69,724 2,26,526 2,71,560 2,93,554 2,62,252
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 47,943 27,156 1,00,238 65,033 37,573 1,04,285
ROE (net income / shareholders' equity) 25.9% 23.5% 21.4% 17.2% 20.4% 21.7%
ROA (Net income/ Total Assets) 15.5% 14.5% 13.2% 10.3% 12% 11.5%
Assets 1 4,76,261 5,12,395 5,66,500 6,28,534 6,95,230 7,29,044
Book Value Per Share 2 26,007 35,585 39,022 41,669 45,838 36,774
Cash Flow per Share 2 18,209 18,186 12,325 3,153 4,013 1,420
Capex 1 8,436 9,359 9,687 3,962 5,318 8,012
Capex / Sales 1.86% 2.01% 2.1% 0.96% 1.13% 1.65%
Announcement Date 28/03/19 27/03/20 23/03/21 31/03/22 29/03/23 28/03/24
1VND in Million2VND
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
PHARMEDIC PHARMACEUTICAL MEDICINAL Stock Pharmedic Pharmaceutical Medicinal
+0.81% 3.2Cr
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+38.51% 72TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+34.28% 59TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.27% 37TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.08% 33TCr
ABBVIE INC. Stock AbbVie Inc.
+2.88% 28TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.02% 24TCr
NOVARTIS AG Stock Novartis AG
+9.31% 21TCr
ROCHE HOLDING AG Stock Roche Holding AG
-5.07% 21TCr
PFIZER, INC. Stock Pfizer, Inc.
+0.03% 17TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. PMC Stock
  4. Financials Pharmedic Pharmaceutical Medicinal